Year archive

Citi Pharma Ltd. — 2025 filings

All 29 regulatory filings released by Citi Pharma Ltd. (CPHL) in 2025, sourced directly from the official regulator.

29 Filings

2025 Period

2025 filings (29)

Filing	Released	Lang
Certified True Copy of the Resolutions Passed in the Annual General Meeting Regulatory Filings	2025-11-13	English
Credit of Final Cash Dividend (2025) Regulatory Filings	2025-11-06	English
TRANSMISSION OF QUARTERLY REPORT FOR THE PERIOD ENDED Regulatory Filings	2025-10-30	English
Financial Results for the Quarter Ended Regulatory Filings	2025-10-29	English
Notice of Election of Directors u/s 159(4) of the Companies Act, 2017 Regulatory Filings	2025-10-20	English
CLARIFICATION REGARDING NEWS CIRCULATING ON SOCIAL MEDIA PLATFORMS Regulatory Filings	2025-10-16	English
Transmission of Annual Report for the Year Ended Regulatory Filings	2025-10-07	English
Notice of Annual General Meeting Regulatory Filings	2025-10-06	English
Financial Results for the year ended Regulatory Filings	2025-10-02	English
Material Information Regulatory Filings	2025-09-12	English
Certified Copy of the Resolutions adopted in the Extra Ordinary General Meeting of Citi Pharma Limited , held on Thursday 26 June 2025 Regulatory Filings	2025-06-26	English
Notice of Extra ordinary general meeting Regulatory Filings	2025-06-13	English
Notice of extraordinary general meetingREVOKED Regulatory Filings	2025-06-13	English
Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations Regulatory Filings	2025-05-21	English
Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX RegulationsREVOKED Regulatory Filings	2025-05-19	English
Transmission of financial statements for the Nine Months period ended 31 March 2025 Regulatory Filings	2025-05-02	English
Financial Results for the Quarter ended Regulatory Filings	2025-04-30	English
EXTRACT OF RESOLUTION PASSED VIA CIRCULATION Regulatory Filings	2025-04-16	English
Material Information Regulatory Filings	2025-04-16	English
Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations Regulatory Filings	2025-03-04	English
Transmission of Quarterly Financial Statements for the Half Year Ended 31 December 2024 Regulatory Filings	2025-03-03	English
Financial Results for the Quarter ended December 31, 2024 Regulatory Filings	2025-02-28	English
Material Information Regulatory Filings	2025-02-27	English
Half Yearly Progress Report for utilization of the proceeds for the half year ended December 31, 2023 Regulatory Filings	2025-02-12	English
Half Yearly Progress Report for utilization of the proceeds for the half year ended December 30, 2023REVOKED Regulatory Filings	2025-02-11	English
Annual Progress Report for the year ended June 30, 2024 Regulatory Filings	2025-02-11	English
Post meeting Briefing Regulatory Filings	2025-02-07	English
Decision of the Board Meeting Held on 2025-02-06 Regulatory Filings	2025-02-07	English
Board Meeting Other Than Financial Results Regulatory Filings	2025-01-30	English